| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Curis Inc (CRIS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 2 sells. CRIS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 360.0K | $202.0K | - | |
| CFO | 135.0K | $75.7K | - | |
| Other | 135.0K | $75.7K | - | |
| Dir | 14.4K | $8.1K | - | |
| Dir | 14.4K | $8.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2015 | Passeri Daniel R | Director | Sale+OE | 289,000 | $2.99 | $863,450.00 | -42.1% |